- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Bottomley Consulting Group
Bottomley Consulting Group is listed as a small consultant research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small consultant
Brand Communications
- Patient-HCP Communication Aids Design and development of tools (visuals, guides, devices) that facilitate clear, accurate, and empathetic two-way dialogue between patients and their healthcare providers.
Clinical Consulting
- Clinical Consulting Provide high quality data, on time and within budget, while maintaining the flexibility in delivering personalized services.
- Clinical Protocol Design & Development Creation of clinical protocol document which details how a clinical trial is designed, relating to to the methodology, hypothesis, and operation of clinical trial to ensure the safety of the patients is...
- Clinical Study Reporting (CSR) Report results of clinical trials to regulatory agencies. This includes participant flow, baseline characteristics, outcome measures, statistical analyses, and adverse events.
- Clinical Trial Consulting Consulting services for Clinical trials.
- Clinical Trial Recruitment Recruitment, enrollment and retention of patients for clinical trials.
- IND Writing Consulting Consulting for an Investigational New Drug Application
Clinical Trials
- Case Report Monitoring & Auditing Ensure the adequate collection and traceability of clinical data in preparation for review by the FDA.
- Clinical Biostatistical Services Analyze and interpret data throughout all phases of clinical trial development.
- Clinical Research Services Determine the safety and effectiveness of medications and medical devices.
- Clinical Trial Design Develop study-related protocols, case report forms (CRFs) and database tools for records management.
- eCOA - Electronic Clinical Outcomes Assessments Use smartphones, computers and tablets to allow patients to directly report health outcomes.
- ePRO - Electronic Patient-reported Outcome Patient reported outcome collected by electronic methods.
Show all 12 in Clinical Trials
- Patient Insights Data, information, and feedback collected from patients to understand their experiences, perspectives, and needs related to a particular health condition or treatment
- Patient Recruitment Recruit and retain patients for clinical trials.
- Phase 1-3 Studies Design phase 1-3 studies that seek to identify if a drug is safe, effective, and more efficient than other available treatments on the market.
- Post-Marketing (Phase 4) Studies Conduct phase 4 studies for confirming unrecognized safety issues, investigating possible hazards or establishing the expected safety profile of a veterinary medicinal product under market conditions.
- Prospective Explorative Studies Conduct a prospective exploratory study to assess the safety and efficacy of a test drug during clinical trials.
- Trial Phase: Open Trials Clinical Trial Intelligence
Show all 86 services
Creative
- Case Studies Recruit research participants with a behavioral condition to receive either an investigational behavioral intervention or a behavioral intervention in clinical use.
Data Science/Bioinformatics
- Clinical Data Analysis Analysis that helps you make sense of your clinical data
- Clinical Data Science and Modeling A process that helps make sense of your clinical data
- Clinical Responder Analysis, Patient Stratification The process of identifying patients that are more likely to respond positively to a drug.
- Discovery Databases Databases specifically designed for drug discovery use.
- Graph-Based Patient Journey Analysis Graph-based patient journey analysis is a method of visualizing and analyzing the pathways patients take through healthcare systems using graph structures, enabling insights into patient experiences, care patterns...
- RWE/HEOR Drug Response Analysis A process to understand how a population is responding to a drug, specifically if there are any adverse events.
Show all 7 in Data Science/Bioinformatics
- RWE/HEOR Software Tools Software designed to serve the needs of RWE/HEOR research groups.
Disease Models
- Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
- Huntington's Disease Models Measure therapeutic endpoints in animal models of Huntington's disease.
- Olfactory Testing Models Measure therapeutic endpoints in animal models of olfactory function.
General Marketing
- Database Management Software Facilitate the collection, tracking and processing of biological facts, statistics and observations.
HEOR
- Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
- Clinical Outcome Assessments (Non-Patient Reported) Measure a patient's symptoms, mental state and level of disease condition-related impact on daily life.
- Clinical Outcomes Measures patient's symptoms, mental, or physical effects of a disease or condition on how the patient functions, recorded by practitioner, provider, or instrument (not by patient).
- Comparative Effectiveness The generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or to improve the delivery of care.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- HEOR Adherence Studies Strategy or study that assess extent to which patients or subjects follow recommendations for prescribed intervention; may include compliance assessment, as well as reasons related to actual or potential non-adherence.
Show all 8 in HEOR
- Patient Reported Outcomes (PRO) Assessment of health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician.
- Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Market Access
- Market Access Materials Find general strategies and methods used to market a pharmaceutical product or device.
- Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
- Population Health Analytics Aggregation of patient data across multiple health information technology resources, the analysis of that data into a single, actionable patient record, and the actions through which care providers can improve both...
Medical Communications
- Abstracts Request services related to the writing and review of abstracts
- Case Reviews Review medical cases from Clinical Trials.
- Consensus reports Develop and submit a report that is a comprehensive examination by an expert panel of a scientific or medical issue.
- Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier Develop and submit Investigational Medicinal Product Dossier (IMPD) and Investigational New Drug (IND) Dossier
- Layperson Clinical Trial Result Dissemination Layperson clinical trial result dissemination involves translating complex clinical trial findings into clear, accessible language so that non-experts can easily understand the outcomes and implications.
- Linguistic Validation Ensure translations of patient questionnaires, like those used in clinical trials, are both accurate and culturally appropriate for the target audience
Show all 15 in Medical Communications
- Literature Monitoring Ongoing, systematic surveillance and analysis of published scientific literature to track emerging data, competitor activities, and changes in clinical understanding.
- Medical Literature Reviews Systematic searching, appraisal, and synthesis of published scientific literature to generate evidence-based reports on a specific topic, disease, or treatment.
- Medical Publications Make clear and accurate presentations of scientific and technical data.
- Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
- Medicinal Product Non- Clinical Outcome Determine potential outcomes for products in a non-clinical setting.
- Patient Advocacy Group Engagement Compliant collaboration and information sharing with non-profit organizations that represent patient communities to understand their needs and provide education.
- Patient Narratives Compliant collection and use of individual patient stories to illustrate the impact of a disease or treatment, often for training or empathy-building purposes.
- Protocol and Study Reports Write protocol and study reports, specifically relating to the drafting, writing, and editing of Clinical Safety Reports.
- Review Article/ Submission Drafting and managing the process of submitting an objective, comprehensive summary of the current literature on a disease or treatment area to a peer-reviewed journal.
Medical/Commercial
- Health & Pharmacoeconomics Identify, measure and compare the cost-benefit ratio of products and services.
Old Category HEOR, RWE, Market Access
- Non-Interventional Studies Examine different aspects of drug usage, including efficacy and safety, under real-life conditions.
- Patient-Reported Outcome Studies Get self-reported information regarding the personal health status of an individual.
- RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
- RWE/RWD Enriched Studies Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Primary Market Research
- In-depth interviews (IDIs) One-on-one qualitative interviews conducted with key stakeholders to explore beliefs, decision drivers, and unmet needs. Delivers rich narrative data to inform trial design, product positioning, and message development.
- Journey Mapping (Patient, HCP, Payer) Visual representation of stakeholder experiences across disease or treatment timelines. Identifies pain points, decision triggers, and opportunities for engagement or support.
- Online/phone surveys Quantitative questionnaires deployed via web or telephone to gather feedback from large, targeted populations. Results offer statistically significant insights for trend analysis, segmentation, and tracking.
- Unmet Need and SoC Validation Assesses perceived gaps in current standards of care and the need for new interventions. Supports value proposition development and market shaping.
Real World Evidence & Data
- Exploratory Study Explore study design, outcomes, data-collection method, and selection of population for a topic that needs more research information.
- Meta-Analysis Use quantitative statistical approaches to pool results across multiple studies to improve power or resolve uncertainty; may be used in conjunction with a systematic review.
- Non-Comparative Study Assess an intervention using a single arm study design (without a control or comparator group).
- Patient Reported Outcomes (PRO) Databases Database or collection of data related to health outcomes directly reported by the patient who experienced it, without interpretation of the patient's response by a clinician or anyone else.
- Pragmatic Clinical Trial Randomized trial comparing two or more treatments in a real world setting. The trial possesses minimal exclusion criteria and closely follows the procedures of the clinical practice in order to mirror clinical care...
- Real World Evidence (RWE) Studies Studies (prospective or retrospective) utilizing data obtained from "real world settings" , and is outside the tight controls of a clinical trial design.
Show all 16 in Real World Evidence & Data
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- Real-World Evidence Acquire clinical data from patients' medical records to analyze trends and the frequency of occurrence of different medical conditions.
- Retrospective Exploratory Studies Retrospective exploratory studies
- RWD - COVID-19 Data from COVID-19 patients, can include diagnosis, treatment, among others.
- RWD - Oncology Data from oncology patients, can include clinical treatment, diagnosis, among others.
- RWD - Rare Diseases Data from patients with rare diseases, can include clinical treatment, diagnosis, among others.
- RWD - Wearables Data gathered from sources including pedometers, mobile devices, smart watches, among others.
- RWE/HEOR Data Analysis Analysis that helps you make sense of your RWE/HEOR data
- RWE/RWD Observational Research Research method for documenting clinical, economic, and or humanistic outcomes of actual medical practice absent the constraints of a more formal experimental design. See also Pragmatic Clinical Trials.
- Secondary Real World Evidence Analyze clinical trial data.
Regulatory Affairs
- Safety Signals Early indication that a new or unknown adverse event occurred that may be caused by treatment and investigation is needed to determine a causal relationship. Can be investigated through spontaneous reports, studies...
Scientific Data Services
- Database Integration Convert bioinformatics results from multiple data sources (DSs) into a single operational format.
Other services
- Observational Research Gain valuable insights into the association between a drug treatment and its outcomes such as long-term effectiveness and safety.
- Rare Diseases Recruitment of volunteers or study participants who have a rare disease, or specifically in the "U.S.when a chronic and enervating condition afflicts fewer than 200,000 people combined, and in the EU, when it affects...
Where it operates
Sites by country, with the cities in each.
-
Belgium 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
- Professional associations
- Cancer Commons
- Website
- Www.Andrew-bottomley.com
Work with Bottomley Consulting Group on Scientist.com
For prices, more details, or to contact Bottomley Consulting Group, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.